Drawing for INQOVI

USPTO serial 79282613

INQOVI

Reg. 6177299Status 700Renewal
Filing date
Feb 12, 2020
Status date
Oct 20, 2020
Registration date
Oct 20, 2020
Examiner
MAHMOUDI, MARIAM AZIZ

Need help with INQOVI?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Deadline: October 20th, 2026

Owner

  • Otsuka Pharmaceutical Co., Ltd.

    JP

  • Otsuka Pharmaceutical Co., Ltd.

    JP

  • Otsuka Pharmaceutical Co., Ltd.

    JP

  • TAIHO PHARMACEUTICAL CO., LTD.

    JP

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for treating cancer; pharmaceutical preparations for treating immune disorders; pharmaceutical preparations for treating hematological disordersACTIVE

Prosecution history

DateCodeEvent
Oct 20, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 26, 2024CHLDCHANGE OF OWNER RECEIVED FROM IB
Mar 1, 2021FINVFINAL DECISION TRANSACTION PROCESSED BY IB
Feb 10, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB
Feb 10, 2021FIMPFINAL DISPOSITION PROCESSED
Jan 20, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 20, 2020R.PRREGISTERED-PRINCIPAL REGISTER
Aug 4, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 4, 2020PUBOPUBLISHED FOR OPPOSITION
Jul 31, 2020GPNXNOTIFICATION PROCESSED BY IB
Jul 15, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 15, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 15, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 30, 2020ALIEASSIGNED TO LIE
Jun 29, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 29, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2020RFNTREFUSAL PROCESSED BY IB
May 14, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 14, 2020RFRRREFUSAL PROCESSED BY MPU
May 2, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 1, 2020CNRTNON-FINAL ACTION WRITTEN
Apr 30, 2020DOCKASSIGNED TO EXAMINER
Apr 24, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Apr 20, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 9, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Related guidance